Ticker
AYTUCompany Name
AYTU BIOPHARMA INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Free Cash Flow | Free Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -1.5M | -2.26% | $ 66.38M |
3/31/2025 | $ -5.07M | -7.33% | $ 69.22M |
12/31/2024 | $ 1.2M | 1.74% | $ 68.76M |
9/30/2024 | $ -1.99M | -2.63% | $ 75.48M |
6/30/2024 | $ -1.39M | -1.71% | $ 81M |
3/31/2024 | $ 8.77M | 9.35% | $ 93.76M |
12/31/2023 | $ 6.11M | 6.21% | $ 98.5M |
9/30/2023 | $ 3.81M | 3.74% | $ 101.84M |
6/30/2023 | $ -5.13M | -4.78% | $ 107.4M |
3/31/2023 | $ -21.59M | -20.74% | $ 104.11M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Revenues
(=) FCF %
FCF % for AYTU BIOPHARMA INC is calculated as follows: FCF [ $ -33.36M ] / Revenues [ $ 39.71M ]
(=) FCF % [ -84.01% ]
Minimum
Sep 30, 2020
Maximum
Mar 31, 2024
Average
Median
filtered constituents | 3.18K |
---|---|
min | -58.23% |
max | 68.19% |
average | 7.85% |
median | 7.37% |
std | 19.48% |